Scancell (LON:SCLP) Share Price Crosses Below 200-Day Moving Average – Should You Sell?

Scancell Holdings plc (LON:SCLP) shares passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 10.56 ($0.14) and traded as low as GBX 9.60 ($0.13). Scancell shares last traded at GBX 9.87 ($0.13), with a volume of 211,197 shares changing hands.

Scancell Stock Performance

The stock has a market cap of £105.13 million, a price-to-earnings ratio of -15.56 and a beta of 0.35. The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01. The stock’s 50-day moving average is GBX 9.15 and its 200-day moving average is GBX 10.56.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.